Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors

Journal of Investigative Dermatology

Volumn 115, Issue 5, 2000, Pages 893-900

  Simonart, Thierry ^f   Degraef, Chantal ^a   Andrei, Graciela ^b   Mosselmans, Roger ^a   Hermans, Philippe ^c   Van Vooren, Jean Paul ^d   Noel, Jean Christophe ^d   Boelaert, Johan R ^e   Snoeck, Robert ^b   Heenen, Michel ^f  

^a IRIBHN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e General Hospital St Jan   (Belgium)

^f NONE

Author keywords

Cyclin D1; Deferiprone; Desferrioxamine; p34 cyclin dependent kinase 4

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DEFERIPRONE; DEFEROXAMINE; IRON CHELATING AGENT; KI 67 ANTIGEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IRON CHELATION; IRON METABOLISM; KAPOSI SARCOMA; PRIORITY JOURNAL; SARCOMA CELL;

EID: 0033739992     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00119.x     Document Type: Article

References (46)

1. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus
2. Impairment of nucleotide metabolism by iron-chelating deferoxamine
3. Establishment and characterization of two new Kaposi's sacoma cell cultures from an AIDS and a non-AIDS patient
4. Constitutive release of metalloproteinase-9 (92-kDa type IV collagenase) by Kaposi's sarcoma cells
5. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma
6. Neuroblastoma sensitivity to growth inhibition by desferrioxamine: Evidence for a block in G1 phase of the cell cycle
7. Vascular tumors. Tumors and tumors-like conditions of blood vessels and lymphatics
8. The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma
9. Early and late stage Kaposi's sarcoma lesions exhibit similar proliferation fraction
10. Effects of single course of deferoxamine in neuroblastoma patients
11. Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis
12. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
13. In vitro and in vivo effects of deferoxamine in neonatal acute leukemia
14. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line
15. Iron deprivation-induced apoptosis in HL-60 cells
16. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes
17. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells
18. Methotrexate induces apoptotic cell death in human keratinocytes
19. Iron chelators induces apoptosis in proliferating cells
20. High incidence of classical KS in Iceland and the Faroe Islands
21. Cyclin D1 and retinoblastoma expression in KS
22. Heterogeneity of spindle cells in KS, comparison of cells in lesions and in culture
23. Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells
24. Direct binding of cyclin D to the retinoblastoma gene product (pRB) and pRB phosphorylation by the cyclin D-dependent kinase, CDK4
25. Mechanism of sustained E-selectin expression in human dermal microvascular endothelial cells
26. Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines
27. Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13
28. The proto-oncogene Bcl-2 and its role in regulating apoptosis
29. Hypochromic anemia
30. Desferrioxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
31. Tumorigenesis and metastasis of neoplastic KS cell line in immunodeficient mice blocked by a human pregnancy hormone
32. Overexpression of the Bcl-2 protein increases the half-life of p21Bax
33. A novel cyclin encoded by a bcl1-linked candidate oncogene
34. Transferrin and transferrin receptors in carcinoma of the breast
35. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma
36. Ordering the cell death pathway
37. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells
38. Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells
39. G1 phase progression: Cycling on cue
40. Iron as a potential cofactor in the pathogenesis of Kaposi's sarcoma
41. Overexpression of Bcl-2 in Kaposi's sarcoma-derived cells
42. High prevalence of KS in Iceland and the Faroe Islands
43. Desferoxamine: A scavenger of superoxide radicals?
44. Iron in cancer
45. The role of iron in cancer
46. Endemic KS in Africa and local volcanic soils